Artykuły w czasopismach na temat „Targeted nanotherapy”
Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych
Sprawdź 50 najlepszych artykułów w czasopismach naukowych na temat „Targeted nanotherapy”.
Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.
Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.
Przeglądaj artykuły w czasopismach z różnych dziedzin i twórz odpowiednie bibliografie.
Kim, Gloria J., i Shuming Nie. "Targeted cancer nanotherapy". Materials Today 8, nr 8 (sierpień 2005): 28–33. http://dx.doi.org/10.1016/s1369-7021(05)71034-8.
Pełny tekst źródłaMathew, Anila, Toru Maekawa i D. Sakthikumar. "Aptamers in Targeted Nanotherapy". Current Topics in Medicinal Chemistry 15, nr 12 (17.04.2015): 1102–14. http://dx.doi.org/10.2174/1568026615666150413153525.
Pełny tekst źródłaZhu, Peng, Carl Atkinson, Suraj Dixit, Qi Cheng, Danh Tran, Kunal Patel, Yu-Lin Jiang i in. "Organ preservation with targeted rapamycin nanoparticles: a pre-treatment strategy preventing chronic rejection in vivo". RSC Advances 8, nr 46 (2018): 25909–19. http://dx.doi.org/10.1039/c8ra01555d.
Pełny tekst źródłaCrintea, Andreea, Anne-Marie Constantin, Alexandru C. Motofelea, Carmen-Bianca Crivii, Maria A. Velescu, Răzvan L. Coșeriu, Tamás Ilyés, Alexandra M. Crăciun i Ciprian N. Silaghi. "Targeted EGFR Nanotherapy in Non-Small Cell Lung Cancer". Journal of Functional Biomaterials 14, nr 9 (9.09.2023): 466. http://dx.doi.org/10.3390/jfb14090466.
Pełny tekst źródłaNarayanan, Sreeja, N. S. Binulal, Ullas Mony, Koyakutty Manzoor, Shantikumar Nair i Deepthy Menon. "Folate targeted polymeric ‘green’ nanotherapy for cancer". Nanotechnology 21, nr 28 (28.06.2010): 285107. http://dx.doi.org/10.1088/0957-4484/21/28/285107.
Pełny tekst źródłaKatsogiannou, M., L. Peng, C. V. Catapano i P. Rocchi. "Active-Targeted Nanotherapy Strategies for Prostate Cancer". Current Cancer Drug Targets 11, nr 8 (1.10.2011): 954–65. http://dx.doi.org/10.2174/156800911797264770.
Pełny tekst źródłaMetcalfe, Su M., i Tarek M. Fahmy. "Targeted nanotherapy for induction of therapeutic immune responses". Trends in Molecular Medicine 18, nr 2 (luty 2012): 72–80. http://dx.doi.org/10.1016/j.molmed.2011.11.002.
Pełny tekst źródłaHu, Xiankang, i Jianxiang Zhang. "Yeast capsules for targeted delivery: the future of nanotherapy?" Nanomedicine 12, nr 9 (maj 2017): 955–57. http://dx.doi.org/10.2217/nnm-2017-0059.
Pełny tekst źródłaRapoport, N. Ya, K. H. Nam, Z. Gao i A. Kennedy. "Application of ultrasound for targeted nanotherapy of malignant tumors". Acoustical Physics 55, nr 4-5 (18.07.2009): 594–601. http://dx.doi.org/10.1134/s1063771009040162.
Pełny tekst źródłaSoodgupta, Deepti, Dipanjan Pan, Grace Hu, Angana Senpan, Xiaoxia Yang, Katherine N. Weilbaecher, Edward V. Prochownik, Gregory M. Lanza i Michael H. Tomasson. "Preclinical Development Of a Nanomedicne Approach For Multiple Myeloma Targeting The Myc Oncoprotein". Blood 122, nr 21 (15.11.2013): 4228. http://dx.doi.org/10.1182/blood.v122.21.4228.4228.
Pełny tekst źródłaKoneru, Tejaswi, Eva McCord, Shreya Pawar, Katyayani Tatiparti, Samaresh Sau i Arun K. Iyer. "Transferrin: Biology and Use in Receptor-Targeted Nanotherapy of Gliomas". ACS Omega 6, nr 13 (22.03.2021): 8727–33. http://dx.doi.org/10.1021/acsomega.0c05848.
Pełny tekst źródłaKeen, Judith C. "A step towards a new targeted nanotherapy for pancreatic cancer". Cancer Biology & Therapy 7, nr 10 (październik 2008): 1591–92. http://dx.doi.org/10.4161/cbt.7.10.6758.
Pełny tekst źródłaZhou, Xia-Qing, Ya-Ping Li i Shuang-Suo Dang. "Precision targeting in hepatocellular carcinoma: Exploring ligand-receptor mediated nanotherapy". World Journal of Hepatology 16, nr 2 (27.02.2024): 164–76. http://dx.doi.org/10.4254/wjh.v16.i2.164.
Pełny tekst źródłaMarcelo, Gonçalo A., David Montpeyó, Joana Galhano, Ramón Martínez-Máñez, José Luis Capelo-Martínez, Julia Lorenzo, Carlos Lodeiro i Elisabete Oliveira. "Development of New Targeted Nanotherapy Combined with Magneto-Fluorescent Nanoparticles against Colorectal Cancer". International Journal of Molecular Sciences 24, nr 7 (1.04.2023): 6612. http://dx.doi.org/10.3390/ijms24076612.
Pełny tekst źródłaAwad, Noor A., Nahi Y. Yassen, Amer T. Tawfeeq i Kismat M. Turki. "Hybrid nanoliposome as a targeted growth inhibitor for Cervical Carcinoma Cell line". Journal of the Faculty of Medicine Baghdad 57, nr 4 (3.01.2016): 320–24. http://dx.doi.org/10.32007/jfacmedbagdad.574399.
Pełny tekst źródłaAsik, Elif, Yeliz Akpinar, Ayse Caner, Nermin Kahraman, Tulin Guray, Murvet Volkan, Constance Albarracin, Apar Pataer, Banu Arun i Bulent Ozpolat. "EF2-kinase targeted cobalt-ferrite siRNA-nanotherapy suppressesBRCA1-mutated breast cancer". Nanomedicine 14, nr 17 (wrzesień 2019): 2315–38. http://dx.doi.org/10.2217/nnm-2019-0132.
Pełny tekst źródłaZhou, Hui-fang, Happy W. Chan, Samuel A. Wickline, Gregory M. Lanza i Christine T. N. Pham. "α v β 3 –Targeted nanotherapy suppresses inflammatory arthritis in mice". FASEB Journal 23, nr 9 (17.04.2009): 2978–85. http://dx.doi.org/10.1096/fj.09-129874.
Pełny tekst źródłaJournaux, Justine, M. Bejko, P. Clerc, Y. Al Yaman, C. Bousquet, S. Mornet, O. Sandre i V. Gigoux. "Nanotherapy of pancreatic adenocarcinoma by targeted magnetic hyperthermia: efficacy and mechanisms." Pancreatology 22 (listopad 2022): e74-e75. http://dx.doi.org/10.1016/j.pan.2022.06.193.
Pełny tekst źródłaHaque, Sakib, Kiri Cook, Gaurav Sahay i Conroy Sun. "RNA-Based Therapeutics: Current Developments in Targeted Molecular Therapy of Triple-Negative Breast Cancer". Pharmaceutics 13, nr 10 (15.10.2021): 1694. http://dx.doi.org/10.3390/pharmaceutics13101694.
Pełny tekst źródłaKara, Goknur, Pinar Atalay Dundar, Nermin Kahraman, Emir Baki Denkbas i Bulent Ozpolat. "Abstract 461: Dual-kinase targeted miRNA nanotherapy for the treatment of triple-negative breast cancer". Cancer Research 84, nr 6_Supplement (22.03.2024): 461. http://dx.doi.org/10.1158/1538-7445.am2024-461.
Pełny tekst źródłaSajjadi, Mohaddeseh, Mahmoud Nasrollahzadeh, Babak Jaleh, Ghazaleh Jamalipour Soufi i Siavash Iravani. "Carbon-based nanomaterials for targeted cancer nanotherapy: recent trends and future prospects". Journal of Drug Targeting 29, nr 7 (18.02.2021): 716–41. http://dx.doi.org/10.1080/1061186x.2021.1886301.
Pełny tekst źródłaKAJIMOTO, Kazuaki. "Adipose Vasculature Targeted Nanotherapy Leads to a Novel Strategy of Obesity Treatment". Oleoscience 15, nr 3 (2015): 107–14. http://dx.doi.org/10.5650/oleoscience.15.107.
Pełny tekst źródłaKomizu, Yuji, Sayuri Nakata, Koichi Goto, Yoko Matsumoto i Ryuichi Ueoka. "Membrane-Targeted Nanotherapy with Hybrid Liposomes for Tumor Cells Leading to Apoptosis". ACS Medicinal Chemistry Letters 2, nr 4 (13.01.2011): 275–79. http://dx.doi.org/10.1021/ml100269t.
Pełny tekst źródłaAgrahari, Vivek. "The exciting potential of nanotherapy in brain-tumor targeted drug delivery approaches". Neural Regeneration Research 12, nr 2 (2017): 197. http://dx.doi.org/10.4103/1673-5374.200796.
Pełny tekst źródłaDelie, Florence, Patrick Petignat i Marie Cohen. "GRP78-targeted nanotherapy against castrate-resistant prostate cancer cells expressing membrane GRP78". Targeted Oncology 8, nr 4 (23.10.2012): 225–30. http://dx.doi.org/10.1007/s11523-012-0234-9.
Pełny tekst źródłaNguyen, Dai Hai, Jung Seok Lee, Jin Woo Bae, Jong Hoon Choi, Yunki Lee, Joo Young Son i Ki Dong Park. "Targeted doxorubicin nanotherapy strongly suppressing growth of multidrug resistant tumor in mice". International Journal of Pharmaceutics 495, nr 1 (listopad 2015): 329–35. http://dx.doi.org/10.1016/j.ijpharm.2015.08.083.
Pełny tekst źródłaPan, Dipanjan, Benjamin Kim, Grace Hu, Deepti Sood Gupta, Angana Senpan, Xiaoxia Yang, Anne Schmieder i in. "A strategy for combating melanoma with oncogenic c-Myc inhibitors and targeted nanotherapy". Nanomedicine 10, nr 2 (styczeń 2015): 241–51. http://dx.doi.org/10.2217/nnm.14.101.
Pełny tekst źródłaRoss, Michael H., Alison K. Esser, Gregory C. Fox, Anne H. Schmieder, Xiaoxia Yang, Grace Hu, Dipanjan Pan i in. "Bone-Induced Expression of Integrin β3 Enables Targeted Nanotherapy of Breast Cancer Metastases". Cancer Research 77, nr 22 (30.08.2017): 6299–312. http://dx.doi.org/10.1158/0008-5472.can-17-1225.
Pełny tekst źródłaWang, Xiaoxuan, Fangxuan Li, Jialu Zhang, Lu Guo, Mengmeng Shang, Xiao Sun, Shan Xiao i in. "A combination of PD-L1-targeted IL-15 mRNA nanotherapy and ultrasound-targeted microbubble destruction for tumor immunotherapy". Journal of Controlled Release 367 (marzec 2024): 45–60. http://dx.doi.org/10.1016/j.jconrel.2024.01.039.
Pełny tekst źródłaZhang, Qixiong, Fuzhong Zhang, Shanshan Li, Renfeng Liu, Taotao Jin, Yin Dou, Zhenhua Zhou i Jianxiang Zhang. "A Multifunctional Nanotherapy for Targeted Treatment of Colon Cancer by Simultaneously Regulating Tumor Microenvironment". Theranostics 9, nr 13 (2019): 3732–53. http://dx.doi.org/10.7150/thno.34377.
Pełny tekst źródłaPuligujja, Pavan, Mariluz Araínga, Prasanta Dash, Diana Palandri, R. Lee Mosley, Santhi Gorantla, Larisa Poluektova, JoEllyn McMillan i Howard E. Gendelman. "Pharmacodynamics of folic acid receptor targeted antiretroviral nanotherapy in HIV-1-infected humanized mice". Antiviral Research 120 (sierpień 2015): 85–88. http://dx.doi.org/10.1016/j.antiviral.2015.05.009.
Pełny tekst źródłaNg, Thomas S. C., David Wert, Hargun Sohi, Daniel Procissi, David Colcher, Andrew A. Raubitschek i Russell E. Jacobs. "Serial Diffusion MRI to Monitor and Model Treatment Response of the Targeted Nanotherapy CRLX101". Clinical Cancer Research 19, nr 9 (26.03.2013): 2518–27. http://dx.doi.org/10.1158/1078-0432.ccr-12-2738.
Pełny tekst źródłaSong, Xinhao, Mengjuan Lin, Tian Fang, Jiahao Gong, Junqi Wang, Shasha Gao, Xiaolin Xu i in. "Maduramicin-guided nanotherapy: A polymeric micelles for targeted drug delivery in canine mammary tumors". Biomedicine & Pharmacotherapy 170 (styczeń 2024): 116062. http://dx.doi.org/10.1016/j.biopha.2023.116062.
Pełny tekst źródłaJiang, Quzi, Luodan Yu i Yu Chen. "Engineering Self-Assembled Nanomedicines Composed of Clinically Approved Medicines for Enhanced Tumor Nanotherapy". Nanomaterials 13, nr 18 (5.09.2023): 2499. http://dx.doi.org/10.3390/nano13182499.
Pełny tekst źródłaGolzar, Hossein, Fatemeh Yazdian, Mohadeseh Hashemi, Meisam Omidi, Dorsa Mohammadrezaei, Hamid Rashedi, Masoumeh Farahani, Nazanin Ghasemi, Javad Shabani shayeh i Lobat Tayebi. "Optimizing the hybrid nanostructure of functionalized reduced graphene oxide/silver for highly efficient cancer nanotherapy". New Journal of Chemistry 42, nr 15 (2018): 13157–68. http://dx.doi.org/10.1039/c8nj01764f.
Pełny tekst źródłaJanani, Balakarthikeyan, Mayakrishnan Vijayakumar, Kannappan Priya, Jin Hee Kim, D. S. Prabakaran, Mohammad Shahid, Sameer Al-Ghamdi i in. "EGFR-Based Targeted Therapy for Colorectal Cancer—Promises and Challenges". Vaccines 10, nr 4 (24.03.2022): 499. http://dx.doi.org/10.3390/vaccines10040499.
Pełny tekst źródłaLin, Mingzhen, Lili Teng, Yang Wang, Jiaxin Zhang i Xianglian Sun. "Curcumin-guided nanotherapy: a lipid-based nanomedicine for targeted drug delivery in breast cancer therapy". Drug Delivery 23, nr 4 (23.07.2015): 1420–25. http://dx.doi.org/10.3109/10717544.2015.1066902.
Pełny tekst źródłaKhan, Suliman, Majid Sharifi, Jason P. Gleghorn, Mohammad Mahdi Nejadi Babadaei, Samir Haj Bloukh, Zehra Edis, Mohammadreza Amin i in. "Artificial engineering of the protein corona at bio-nano interfaces for improved cancer-targeted nanotherapy". Journal of Controlled Release 348 (sierpień 2022): 127–47. http://dx.doi.org/10.1016/j.jconrel.2022.05.055.
Pełny tekst źródłaZhang, Jin. "The Application of Targeted Nanodrugs with Dual Responsiveness of PH and Ros in Preventing and Treating Vascular Restenosis". Journal of Healthcare Engineering 2021 (26.11.2021): 1–6. http://dx.doi.org/10.1155/2021/3982158.
Pełny tekst źródłaGupta, Tanvi, Tilahun Ayane Debele, Yu-Feng Wei, Anish Gupta, Mohd Murtaza i Wen-Pin Su. "Synergistic Action of Immunotherapy and Nanotherapy against Cancer Patients Infected with SARS-CoV-2 and the Use of Artificial Intelligence". Cancers 14, nr 1 (2.01.2022): 213. http://dx.doi.org/10.3390/cancers14010213.
Pełny tekst źródłaMitri, Fabio Franceschini. "Advances of the Nanotechnology in Targeted Nanomedicines for Treatment of Bone Cancers and Diseases". Journal of Cancer Research Updates 10 (30.12.2021): 32–45. http://dx.doi.org/10.30683/1929-2279.2021.10.05.
Pełny tekst źródłaWu, Jianrong, Zheying Meng, Agata A. Exner, Xiaojun Cai, Xue Xie, Bing Hu, Yu Chen i Yuanyi Zheng. "Biodegradable cascade nanocatalysts enable tumor-microenvironment remodeling for controllable CO release and targeted/synergistic cancer nanotherapy". Biomaterials 276 (wrzesień 2021): 121001. http://dx.doi.org/10.1016/j.biomaterials.2021.121001.
Pełny tekst źródłaYoo, Byunghee, Amol Kavishwar, Alana Ross, Ping Wang, Doris P. Tabassum, Kornelia Polyak, Natalia Barteneva i in. "Combining miR-10b–Targeted Nanotherapy with Low-Dose Doxorubicin Elicits Durable Regressions of Metastatic Breast Cancer". Cancer Research 75, nr 20 (10.09.2015): 4407–15. http://dx.doi.org/10.1158/0008-5472.can-15-0888.
Pełny tekst źródłaBariana, Manpreet, Beilu Zhang, Jingyu Sun, Elena Cassella, Janice Rateshwar, Ming Tony Tan, Weiwei Wang i in. "Targeted Nanotherapy of Hematologic Malignancies Using Gold Nanoframework-Based Delivery of a Novel NF-Kb Inhibitor". Blood 140, Supplement 1 (15.11.2022): 6018–19. http://dx.doi.org/10.1182/blood-2022-160324.
Pełny tekst źródłaTrandafir, Laura M., Gianina Dodi, Otilia Frasinariu, Alina C. Luca, Lacramioara I. Butnariu, Elena Tarca i Stefana M. Moisa. "Tackling Dyslipidemia in Obesity from a Nanotechnology Perspective". Nutrients 14, nr 18 (13.09.2022): 3774. http://dx.doi.org/10.3390/nu14183774.
Pełny tekst źródłaReddy, Hrushikesh, G. Jyothi, Maheshwari, D.Prasad i M.Sudhakar. "Nanoliposomes-A Review". World Journal of Pharmaceutical Sciences 10, nr 03 (2022): 299–307. http://dx.doi.org/10.54037/wjps.2022.100308.
Pełny tekst źródłaSILVA, ADRIANA L. DA, RAQUEL S. SANTOS, DÉBORA G. XISTO, SILVIA DEL V. ALONSO, MARCELO M. MORALES i PATRICIA R. M. ROCCO. "Nanoparticle-based therapy for respiratory diseases". Anais da Academia Brasileira de Ciências 85, nr 1 (5.03.2013): 137–46. http://dx.doi.org/10.1590/s0001-37652013005000018.
Pełny tekst źródłaMahajan, Supriya, Ravikumar Aalinkeel, Jessica Reynolds, Bindukumar Nair, Donald Sykes, Wing-Cheung Law, Paras Prasad i Stanley Schwartz. "Innovative nanotherapy for the treatment of the chronic skin condition, rosacea. (P3259)". Journal of Immunology 190, nr 1_Supplement (1.05.2013): 192.15. http://dx.doi.org/10.4049/jimmunol.190.supp.192.15.
Pełny tekst źródłaNewton, Emily R., David C. Gillis, Kui Sun, Brooke R. Dandurand, Robin Siletzky, Suvendu Biswas, Mark R. Karver, Nick D. Tsihlis, Samuel I. Stupp i Melina R. Kibbe. "Evaluation of a Targeted Drug‐Eluting Intravascular Nanotherapy to Prevent Neointimal Hyperplasia in an Atherosclerotic Rat Model". Advanced NanoBiomed Research 1, nr 7 (3.05.2021): 2000093. http://dx.doi.org/10.1002/anbr.202000093.
Pełny tekst źródłaHalling Folkmar Andersen, Anna, i Martin Tolstrup. "The Potential of Long-Acting, Tissue-Targeted Synthetic Nanotherapy for Delivery of Antiviral Therapy Against HIV Infection". Viruses 12, nr 4 (7.04.2020): 412. http://dx.doi.org/10.3390/v12040412.
Pełny tekst źródła